Livagen
Status
No approved product. No FDA-approved labeling exists. Not an FDA-approved medicine. Status in Russia and other countries was not verified for this entry.
What it is
A peptide related to Epitalon studied for chromatin and blood markers.
What published research measured
A synthetic short peptide from the Khavinson bioregulator programme, directed at liver tissue, and described in that group's publications as influencing chromatin decondensation in lymphocytes. Its evidence position is similar to the other synthetic bioregulators in this library: preclinical and small observational work from a single institute, largely in Russian-language journals, and this entry cites no registered clinical trial and no independent replication outside the originating network. The first comprehensive functional screen of a Khavinson peptide by a laboratory unconnected to the programme returned an essentially null result, which is the most relevant recent development for the whole category.
Source
Khavinson programme publications; 2026 independent functional screen returning a near-null result
Sources
No linked primary source is on file for this entry yet.
Educational use only, never medical advice. No doses.